Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 2

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 2
---
 S-3. As a result, as of the date
of this prospectus, we are eligible to sell up to $11,702,826.50 of shares of our Common Stock under this prospectus, pursuant to General
Instruction I.B.6 of Form S-3.

Our Common Stock
is listed on the Nasdaq under the symbol “LNAI”. On December 1, 2025, the last reported sale price of
our Common Stock on Nasdaq was $1.31 per share.

Unless otherwise indicated,
the number of our shares of Common Stock presented in this prospectus supplement is adjusted to reflect the Reverse Stock Split that was
implemented on September 29, 2025. See the section entitled “Prospectus Supplement Summary—Reverse Stock Split” for
more information.

Investing in our Common Stock involves a high deg ree of r isk. S ee the “ Risk Factors“ se ction b eginning on page S-7of this p rospectus supplement and page 5 of the ac companying p rospectus, as well as our other filings that a re in corporated by refe rence into this p rospectus supplement and the accompanying p rospectus.

Neither the Securities and Exchange Commission (the “SEC”) nor any state secu rities commission has app roved or disapp roved of these securities or passed upon the adequacy or accuracy of this p rospectus supplement or the accompanying p rospectus. Any rep resentation to the contrary is a criminal offense.

<div align='center'>Dawson James Securities, Inc.

This
prospectus supplement is dated December 2, 2025

TABLE OF CONTENTS</div>

PROSPECTUS SUPP LEMENT

| ABOUT THIS PROSPECTUS SUPPLEMENT                     | S-1  |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | S-2  |
| PROSPECTUS SUPPLEMENT SUMMARY                        | S-3  |
| THE OFFERING                                         | S-7  |
| RISK FACTORS                                         | S-8  |
| USE OF PROCEEDS                                      | S-13 |
| DIVIDEND POLICY                                      | S-14 |
| DILUTION                                             | S-15 |
| DESCRIPTION OF SECURITIES WEARE OFFERING             | S-16 |
| PLAN OF DISTRIBUTION                                 | S-17 |
| LEGAL MATTERS                                        | S-19 |
|